NCT02745444

Brief Summary

The key objective of this pilot study is to assess the molecular mechanisms of renal pre-conditioning by a one-week low-calorie diet in humans. The protective effect of the low-calorie diet and also of the protein-restriction in donor on transplant qualities and functions in receptor will also be investigated. Analysis of transcriptome, lipidome, metabolome, epigenome, proteome und phosphoproteome through tissue samples as well as blood samples for comparison of low-calorie diet, protein-restriction and no-diet groups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

March 29, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

April 20, 2016

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2019

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2020

Completed
Last Updated

September 29, 2021

Status Verified

September 1, 2021

Enrollment Period

4.1 years

First QC Date

March 29, 2016

Last Update Submit

September 28, 2021

Conditions

Keywords

Living kidney transplantationChronic kidney diseaseAcute kidney injury

Outcome Measures

Primary Outcomes (6)

  • Number of differentially regulated genes on a transcriptomic level

    Identification of relevant difference with regard to transcriptome in kidney tissue between patients with low-calorie diet and and no-diet patients.

    up to 1 year upon receipt of the last tissue sample

  • Number of differentially regulated genes on a lipidome level

    Identification of relevant difference with regard to lipidome in kidney tissue between patients with low-calorie diet and and no-diet patients.

    up to 2 years upon receipt of the last tissue sample

  • Number of differentially regulated genes on a metabolome level

    Identification of relevant difference with regard to metabolome in kidney tissue between patients with low-calorie diet and and no-diet patients.

    up to 2 years upon receipt of the last tissue sample

  • Number of differentially regulated genes on a epigenome level

    Identification of relevant difference with regard to epigenome in kidney tissue between patients with low-calorie diet and and no-diet patients.

    up to 2 years upon receipt of the last tissue sample

  • Number of differentially regulated genes on a proteome level

    Identification of relevant difference with regard to proteome in kidney tissue between patients with low-calorie diet and and no-diet patients.

    up to 1 year upon receipt of the last tissue sample

  • Number of differentially regulated genes on a phosphoproteome level

    Identification of relevant difference with regard to phosphoproteome in kidney tissue between patients with low-calorie diet and and no-diet patients.

    up to 2 years upon receipt of the last tissue sample

Secondary Outcomes (4)

  • Change of NGAL in urine

    Preoperative from donor and receptor; 6h, 12h and 24h after renal transplantation from receptor.

  • Cystatin C

    Preoperative and up until 7 days after renal transplantation from receptor.

  • Occurrence of acute kidney injury

    Assessed up to approx. 30 days from date of renal transplantation until date of discharge, which is the end of observation.

  • Maximum postoperative serum creatinine

    Assessed up to approx. 30 days from date of renal transplantation until date of discharge, which is the end of observation.

Study Arms (4)

low-calorie formula diet

OTHER

Donor taking low-calorie formula diet, 50% of basal energy rate, individually calculated with Mifflin-St. Jeor formula.

Dietary Supplement: low-calorie formula diet

no diet

NO INTERVENTION

Donor ingesting food as usual.

protein-restricted diet

OTHER

Donor taking protein-restricted diet according to diet plans of clinical dietetics of University Hospital of Cologne, with unchanged calorie supply, individually calculated with Mifflin-St. Jeor formula.

Dietary Supplement: protein-restricted diet

Normal protein supply

NO INTERVENTION

Donor taking same dishes as protein-restricted diet group but with customary protein levels, with unchanged calorie supply.

Interventions

low-calorie formula dietDIETARY_SUPPLEMENT
low-calorie formula diet
protein-restricted dietDIETARY_SUPPLEMENT
protein-restricted diet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Competent patients
  • Planned living kidney transplantation
  • Provision of informed consent
  • BMI ≥ 18,5 kg/m²

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital of Cologne

Cologne, 50937, Germany

Location

MeSH Terms

Conditions

Renal Insufficiency, ChronicAcute Kidney Injury

Interventions

Diet, Protein-Restricted

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Volker Burst, MD

    Principal Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 29, 2016

First Posted

April 20, 2016

Study Start

April 1, 2015

Primary Completion

May 17, 2019

Study Completion

May 1, 2020

Last Updated

September 29, 2021

Record last verified: 2021-09

Locations